KE Holdings（BEKE.US) Preview:C4Q22 Marked the Beginning of 2023 Recovery

We expect BEKE C4Q22 revenue and non-GAAP NI to be 9% and 64% above consensus. The top line beat is driven by the quick recovery, the bottom line beat is a result of earning leverage;

Equity Bottom-Up

358 Views, 23 Jan 2023 09:00

SUMMARY(Sign Up to Access)

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

Unlimited Research Summaries
Personalised Alerts
Custom Watchlists
Company Data & News
Events & Webinars

Trusted by:

Trusted by:

Already have an account? Sign In Now

Full Insight

(Paid Plans Only)

Discussions

(Paid Plans Only)

WHAT’S TRENDING

Insights

Trending
Latest

Top Quartile

Blue Lotus Research Institute

China TMT research

ChinaInformation TechnologyEquity Bottom-UpThematic (Sector/Industry)

Blue Lotus is a China headquartered research institution covering overseas listed China TMT stocks.

View Full Profile

Price Chart(Sign Up to Access)

Insight Stream

[KE Holdings (BEKE US) Target Price Change]: Raise TP for Better Market Outlook and Profitability
20 Mar 2023
KE Holdings（BEKE.US) Preview:C4Q22 Marked the Beginning of 2023 Recovery
23 Jan 2023
Ke Holdings (BEKE US) – Beke After Ten Seasons; Initiate with Buy
16 Jan 2023
KE Holdings (BEKE US)'s Shortsell Report and Rebuttal - Key Takeaways
23 Dec 2021
Forensics 101 - Revenue Recognition Shenanigans and Key Detection Metrics
16 Nov 2021